OngoingEUCTR 2004-002788-25
This study is comparing Venlafaxine with placebo for people with moderate to severe depression. Participants receive Venlafaxine or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg
- Condition
- Depression
OngoingEUCTR 2020-002787-32
This study is comparing sertraline hydrochloride with placebo for people with with First Episode Psychosis. Participants receive sertraline hydrochloride or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- University of Birmingham
- Condition
- Depression
OngoingEUCTR 2007-006914-41
This study is looking at whether Cipralex 10 mg can help people with Differential responses to Cognitive Behavioural Analysis System of Psychotherapy versus Escitalopram in chronic major depression with and without early trauma. Participants receive the study medicine Cipralex 10 mg and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Dept. of Psychiaty, University of Freiburg
- Condition
- Depression
OngoingEUCTR 2007-000137-19
This study is looking at whether Metopiron can help people with unipolar depressive episode without psychotic features according to DSM-IV-TR. Participants receive the study medicine Metopiron and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- Leiden University Medical Center
- Condition
- Depression
OngoingEUCTR 2015-003957-16
This study is comparing Esketamine with placebo for people with Treatment resistant depression or Elderly. Participants receive Esketamine or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- University Medical Centre Groningen
- Condition
- Depression
OngoingEUCTR 2022-000043-74
This study is looking at care and outcomes for people with depression poor neonatal adaptation syndrome. Direct benefit is not guaranteed, but the study may help researchers improve future care.
DepressionOther
- Countries
- Austria
- Sponsor
- Medical University of Vienna
- Condition
- Depression
OngoingEUCTR 2004-000502-40
This study is looking at whether a digital support tool can help people with with cancer in palliative stage of their illness. Suffering from fatigue with or without decreased concentration, depression or drowsiness, who feel their fatigue is severe enough to decre or Elderly.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- Southampton University Hospitals Trust
- Condition
- Depression
OngoingEUCTR 2010-023473-18
x. Participants receive Valdoxan or Trevilor retard and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Inn-Salzach-Klinikum gGmbH
- Condition
- Depression
OngoingEUCTR 2021-000805-26
This study is looking at a support or therapy approach for people with depression or Elderly. Participants take part in the program or support approach and complete follow-up assessments.
DepressionOther
- Countries
- Norway
- Sponsor
- Østfold Hospital Trust
- Condition
- Depression
OngoingEUCTR 2009-010188-18
This study is looking at whether DULOXETINE can help people with depression, as principal DSM-IV diagnosis combined with chronic pain symptoms as defined bij score of >3 on BPI painlist for at least six weeks or Elderly. Participants receive the study medicine DULOXETINE and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- Eli Lilly Nederland
- Condition
- Depression
OngoingEUCTR 2009-016953-16
x. Participants receive one of the study medicines, such as Cipralex or Solvex, and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Inn-Salzach-Klinikum gGmbH
- Condition
- Depression
OngoingEUCTR 2006-001079-39
This study is looking at whether Duloxetin-Hydrochlorid can help people with Diagnose einer „Major Depression“. Der Gesamtscore der Hamilton-Depressionsskala-17 muß mindestens 15 betragen.
DepressionOther
- Countries
- Germany
- Sponsor
- Universitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Condition
- Depression
OngoingEUCTR 2010-021024-10
This study is comparing Diklofenak with placebo for people with with a recent suicide attempt and a depression. Participants receive Diklofenak or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Sweden
- Sponsor
- Organisation name was not entered
- Condition
- Depression
OngoingEUCTR 2018-001884-21
This study is comparing JNJ-54175446 with placebo for people with depression with an incomplete response to monoaminergic antidepressants and with biomarker profile indicative of inflammation. Participants receive JNJ-54175446 or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom, View results
- Sponsor
- Cambridgeshire and Peterborough NHS Foundation Trust and University of Cambridge
- Condition
- Depression
OngoingEUCTR 2013-001955-11
This study is comparing Psychological Treatment for Emotional Disorders based on evidence. A Cognitive-Behavioral group treatment.
AnxietyOther
- Countries
- Spain
- Sponsor
- Psicofundación. Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicología
- Condition
- Anxiety
OngoingEUCTR 2009-014056-30
This study is looking at whether Venlafaxine can help people with depression or Elderly. Participants receive the study medicine Venlafaxine and complete study visits and assessments.
DepressionOther
- Countries
- France
- Sponsor
- CHU Clermont-Ferrand
- Condition
- Depression
OngoingEUCTR 2014-003385-24
This study is looking at whether Rivastigmine can help people with Interictal delirium during electric convulsive therapy- course or Elderly. Participants receive the study medicine Rivastigmine and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- GGZ inGeest, parner VUmc
- Condition
- Depression
OngoingEUCTR 2012-004079-38
This study is looking at whether AGOMELATINE can help people with Major depressive episode. Participants receive the study medicine AGOMELATINE and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Department of Psychiatry and Psychotherapy
- Condition
- Depression
OngoingEUCTR 2021-005992-38
This study is comparing MIJ821 with placebo for people with Treatment Resistant Depression or Elderly. Participants receive MIJ821 or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Spain, Poland, View results
- Sponsor
- Novartis Farmacéutica, S.A.
- Condition
- Depression
OngoingEUCTR 2022-002757-26
This study is comparing Nelivaptan with placebo for people with depression or Elderly. Participants receive Nelivaptan or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Lithuania, Slovakia, Bulgaria, Germany, Spain
- Sponsor
- HMNC Holding GmbH
- Condition
- Depression
OngoingEUCTR 2022-000574-26
This study is comparing mebufotenin with placebo for people with Treatment-resistant depression. Participants receive mebufotenin or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Ireland, Czech Republic, Poland, Spain
- Sponsor
- GH Research Ireland Limited
- Condition
- Depression
OngoingEUCTR 2022-003743-10
This study is comparing Not applicable with Not applicable for people with Treatment-Resistant Depression or Elderly. Participants receive Not applicable or Not applicable and complete study visits and assessments.
DepressionOther
- Countries
- Germany, Poland, Spain
- Sponsor
- Beckley Psytech Ltd.
- Condition
- Depression
OngoingEUCTR 2018-003252-20
This study is looking at whether Pimavanserin can help people with depression or Elderly. Participants receive the study medicine Pimavanserin and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom, Slovakia, Poland, Finland, View results
- Sponsor
- ACADIA Pharmaceuticals Inc
- Condition
- Depression
OngoingEUCTR 2017-003288-36
This study is looking at whether PSILOCYBIN can help people with Treatment-Resistant Depression or Elderly. Participants receive the study medicine PSILOCYBIN and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom, Czech Republic, Germany, Portugal, Netherlands, Ireland, Denmark, Spain, View results
- Sponsor
- COMPASS Pathways, Ltd
- Condition
- Depression
TerminatedEUCTR 2010-020493-42
This study is comparing VORTIOXETINE with placebo for people with Major Depressive Disoder or Children, Under 18. Participants receive VORTIOXETINE or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Bulgaria, Poland, Latvia, Spain, View results
- Sponsor
- H. Lundbeck A/S
- Condition
- Depression